-
PNAS: How did the COVID-19 super-transmitter come about?
Time of Update: 2021-02-27
Dr. Chad Roy, author of the communication at the National Primate Research Center in Durham and director of infectious disease air biology, said the incidence of exhaled aerosols increased even in asymptomatic COVID-19 cases.
-
Npj Regen Med: Scientists may be developing new treatments for diabetes
Time of Update: 2021-02-27
FEBRUARY 16, 2021 // -- In a recent study published in the international journal npj Regenerative Medicine, scientists from Monash University and others uncovered barriers to cell regeneration in β, and the results may help scientists develop new treatments for diabetes and related diseases such as organ and tissue damage.
-
The essence of the February 5, 2021 issue of Science
Time of Update: 2021-02-27
the study, published In the February 5, 2021 issue of the Journal of Science, is titled "HSP70 Chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells." TDP-43, where RNA binding defects exist, is caused by translated acetylation modification that causes mutations in the ALS or FTD or TDP-43 RNA identification sequences, and phase separation occurs to form an unequistized small body (anisosome), i.e. droplets with symmetrical liquid spheres and liquid cores.
-
Ebiomedicine: a new diagnostic technique for multiple sclerosis
Time of Update: 2021-02-27
Commenting on the importance of this work, Professor Pentti Tienari, Professor of Neuroscience at the University of Helsinki and co-author of the study, said: "THE treatment of MS is most effective and starts early, but very few biomarkers can be used to identify high-risk groups after the onset of optic neuritis.
-
Autophagy: New ideas for HIV infection treatment! Scientists have developed an innovative treatment to optimize the host immune system to eliminate HIV!
Time of Update: 2021-02-27
13, 2021 // -- Scientists urgently need to improve traditional treatments for people with HIV-1 infections, and in a recent study published in the international journal Autophagy, scientists from institutions such as France's National Centre for Labor Safety and Research developed a new treatment to restore the effectiveness of immune cells.
-
Nature: Scientists are calling for vaccines to be developed to prevent future outbreaks
Time of Update: 2021-02-27
Denis Burton and Eric Topol of Scripps Research, wrote an opinion article in the journal Nature, calling on the government to provide substantial financial support for reasonable vaccine design based on broad-based and antibodies.
-
Advances have been made in the analysis and identification of rapid electrochemical sensing of marine pathogenic bacteria
Time of Update: 2021-02-27
Recently, Qin Wei, a researcher at Yantai Coastal Belt Research Institute of the Chinese Academy of Sciences, and his team proposed a new method for biometric sensing of polymer membrane electrodes based on the direct potential response of magnetically controlled biometric molecules, using the dual characteristics of highly selective identification and potential signal conduction of biometric molecules.
-
Gut: Reveals the molecular mechanisms and processes that open tissue repair in inflammatory bowel disease
Time of Update: 2021-02-27
13, 2021 // -- In a recent study published in the international journal Gut, scientists from the University of Leuven and others developed a new method by studying humans and mice that can direct immu
-
Sci Rep:SRC-3 is a key factor in regulating T cells
Time of Update: 2021-02-27
study, published in Scientific Reports, showed that Treg, which eliminates SRC-3 function, does not inhibit the activity of other immune cells.
-
Plos Comput Bio: Mathematical models reveal that children are twice as resistant to COVID-19 as adults
Time of Update: 2021-02-27
to better understand children's susceptibility and contagion, Dattner and colleagues fitted mathematical and statistical models transmitted in the home to a data set of COVID-19 test results from Bnei Brak, Israel's densely populated city.
-
Nat Cancer: Scientists have successfully induced internal conflicts in tumor cells with the hope of treating neuroblastoma
Time of Update: 2021-02-27
February 13, 2021 // -- Neuroblastoma is a malignant solid tumor that occurs mainly in early childhood and originates from immature cells that have degenerated in the sensory nervous system; N cancer
-
BMC Immunol: Blood components in pregnant women can effectively prevent pathological immune responses
Time of Update: 2021-02-27
11, 2021 /--- -- A team of scientists from the Institute of Ecology and Microbiological Genetics at the Urals of the Russian Academy of Sciences (Perm) studied the role of beta-glycoprotein-promoting immune cells in the blood of pregnant women.
-
CDSR: Hydroxychloroquine is not helpful for PATIENTs with COVID-19
Time of Update: 2021-02-27
from India, South Africa and the United Kingdom (LSTM, University of Liverpool, Royal Liverpool University Hospital) provided a systematic review of studies using chloroquine or hydroxychloroquine to treat or prevent COVID-19 diseases.
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19, Cochrane Database of Systematic Reviews (2020).
-
Cell paper details! Reverse! Past exposure to seasonal coronavirus-producing antibodies that cause the common cold does not prevent SARS-CoV-2 infection
Time of Update: 2021-02-26
in a new study, researchers from the University of Pennsylvania and Children's --- Hospital of Philadelphia found that past exposure to the seasonal coronavirus (CoV) that causes the common cold does not produce antibodies to prevent the new coronavirus SARS-CoV-2.
-
Nat Commun: The calcium signaling of T cells in patients with peanut trenneic acid regulation rheumatoid arthritis promotes the occurrence of glioblastitis
Time of Update: 2021-02-26
, the study found that reduced IKAROS expression levels induced by increased ARC activity made T cells more reactive and ultimately led to chronic inflammation in RA and PSA.
-
Allergy: Happy cat smoking is not a dream, shovel officer allergic culprit found
Time of Update: 2021-02-26
To study the clinical effects of bioallergen-specific immunotherapy (AIT) for high-dose CpG admissives, the researchers first constructed a MODEL of BALB/c OlaHsd mice allergic to Feld 1 and then evaluated the ability of humans to withstand the maximum dose of CpG without endotoxins.
-
New drug for multiple sclerosis! Novart Kesimpta: The first subsethic B-cell therapy available at home once a month, won the favor of patients/nurses!
Time of Update: 2021-02-26
February 17, 2021 // -- Novartis recently released a new multicenter survey that shows that the treatment of multiple sclerosis (FOR MS), patients and caregivers prefer to use Sensoready auto-injectors for self-dosing Kesimpta (ofatumumab) rather than auto-injectors for other disease-correcting therapies (84% vs.
-
Adamo single anti-biosimilars! Yuflyma, the first high-concentration, low-volume, orange-free formula, has been approved by the European Union!
Time of Update: 2021-02-26
February 17, 2021 // -- South Korean biopharmaceutical giant Celltrion recently announced that the European Commission (EC) has approved Yuflyma (CT-P17, Adamo monobial-like drug), a biosimilar drug for AbbVie's overweight pound product Humira (Shumeile, common name: adalimumab, Adamo mono-resistant).
-
"New skills" for anti-epileptic "old drugs": powerful reversal of co-brain disorders
Time of Update: 2021-02-26
The study reveals for the first time the pathogenesis of a class of genetic co-relief disorders (spinocerebellar ataxia, autosomal recessive 20, SCAR20) from a new perspective of axon mitochondrial transport, and finds that the anti-epileptic drug propionate significantly slows the disease process in model mice, has strong conversion disorder application value and promises to provide new treatment for co-treatment.
-
Immunome announces the discovery of first in class neutralizing antibodies against new coronavirus variants
Time of Update: 2021-02-26
In the process, Immunome identified antibodies that bind to non-overlapping regions of the prickly protein (non-overlapping regions, including regions containing key mutations) and showed in active tests that it was able to mediate the prosthetic virus that was specific to the South African mutant strain B.1.351.
